Measure the activity of the sympathetic, the parasympathetic nervous system with every heartbeat and the balance trajectory between them. Use the ANSiscope to monitor Chronic pain

Home
The Company
Products
Technology
Applications
Faq
Newsletters
Posters & Presentations
Publications
Press Coverage
Info for Doctors
Info for Reimbursement
Info for Patients
Info for Researchers
Info for Distribution Partners
Info for OEMs
Info for Investors
Links
Contact Us
ANS Forum










 
 
   
 Chronic and Acute Pain

According to a report released in July 2011 by the IOM, over 116 million US adults are burdened by Chronic Pain. The costs incurred due to this affliction are higher than cardiovascular disease, cancer and diabetes combined. They also mention that 20% of pain prescriptions are fraudulent. Abuse of narcotics prescribed by pain practitioners is very high.

According to the 2010 media planner of Pain Medicine News, over 100,000 pain practitioners prescribed $23.5 billion in pain medication in 2009 alone.

According to a health special published by Time magazine in its March 7th 2011 issue, chronic pain is now being recognized as a disease rather than as a consequence of a disease. This has vast implications.

Finally, there has been no way to measure the severity and seriousness of pain. An article in the July 5th 2011 issue of the Walt Street Journal highlights this fact very well. However, help is at hand. Chronic Pain affects the Autonomic Nervous System and we have been able to show that ANS monitoring of chronic pain patients allows one to measure a baseline and monitor the improvement in the pain condition.

The solution offered by Dyansys – the ANSiscope/P-STIM solution- allows the pain practitioner to treat the patient with a non-narcotic methodology and allows him/her to monitor the progress of the patient as the treatment unfolds. The non-narcotic methodology has actually been very well known as cranial electro stimulation (CES). The P-STIM is a very simple and elegant way to perform CES.

 
 
News and Events
American Diabetes Association Recommends screening for Autonomic Neuropathy
 
Screening for autonomic neuropathy should be instituted at diagnosis of type 2 diabetes and 5 years after the diagnosis of type 1 diabetes
 
American Diabetes Association (ADA), Standard of Medical care in Diabetes, 2006
 
Dyansys introduces Portable ECScope for general physicians/ primary care providers
 
Dyansys gains ISO 13485:2003 certification for Portable ANSiscope, Portable ECScope
 

Dyansys is pleased to announces that European office has granted patent on ANSiscope technology for Germany, France & UK countries. Patent Number - 163947

 
Portable ANSiscope approved for FDA Certification
 
Portable ECScope approved for FDA Certification
Dyansys Product Family
The Portable ANSiscope and ECScope Series for family physicians and field applications 
The P-STIM neurostimulation device for treatment of chronic pain
  more  
Dyansys Application
Chronic & Acute Pain
Anesthesiology
Cardiology
Diabetes
Fetal Heart Monitoring
Measurement of autonomic dysfunction
  more  
Copyright © 2009 DyAnsys Inc. All Rights Reserved
Site designed by Uditi Technologies